Abstract
Six-month-old kittens that had been inoculated 6 days previously with feline leukemia virus (FeLV) were treated with either normal goat serum, goat antiserum to FeLV, or goat antiserum to the purified Friend leukemia virus (FLV) gp71. All of the kittens treated with normal goat serum became persistently viremic, whereas up to three-fourths of those treated with the antiviral antisera resisted persistent viremia. These results suggest that viral antigens, in particular, their interspecies determinants, can be used as targets for immunotherapeutic regimens for the prevention and control of diseases induced by oncornaviruses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
